Emerging Infections Program

OMB Control No: 0920-0978	ICR Reference No: 201612-0920-015
Status: Historical Active	Previous ICR Reference No: 201603-0920-001
Agency/Subagency: HHS/CDC	Agency Tracking No: 17IW
Title: Emerging Infections Program
Type of Information Collection: No material or nonsubstantive change to a currently approved collection	Common Form ICR:  No
Type of Review Request: Regular
OIRA Conclusion Action: Approved without change	Conclusion Date: 01/03/2017
Retrieve Notice of Action (NOA)	Date Received in OIRA: 12/30/2016
Terms of Clearance: Previous terms continue: Approved consistent with the understanding that this consolidation will result in the modification and/or discontinuation of related CDC ICRs.

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	02/28/2019	02/28/2019	02/28/2019
Responses	81,420	0	81,420
Time Burden (Hours)	22,806	0	22,806
Cost Burden (Dollars)	0	0	0

---

Abstract: This Non-Substantive Change Request seeks to make minor changes to the following Forms: 1. HUS Surveillance 2. FoodNet Variable List 3. Clostridium difficile Infection (CDI) 4. Resistant Gram-Negative Bacilli Case Report Form 5. Methicillin-resistant Staphylococcus aureus (MRSA) HAIC Case Report Form The changes will have no impact on the burden of data collection

---

Authorizing Statute(s): US Code: 42 USC 301 Name of Law: Public Health Service Act

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	80 FR 26051	05/06/2015
30-day Notice:	Federal Register Citation:	Citation Date:
	80 FR 39780	07/10/2015
Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 25

IC Title Form No. Form Name Shiga toxin producing E. coli Shigella Vibrio Yersinia Resistant Gram-Negative Bacilli Case Report Form VERSION: 11/2017, VERSION:01-2016, NA 2015 Multi-site Gram-Negative Surveillance Initiative (MuGSI) Healthcare Associated Infection Community Interface (HAIC) Case Report ,   2016 Multi-site Gram Negative Surveillance Initiative (MuGSI) Healthcare Associated Infection Community Interface (HAIC) Case Report ,   2017 Multi-site Gram-Negative Surveillance Initiative (MuGSI) HAIC Case Report CDI Case Report Form CDC Rev 09-2016, CDC Rev.10-2015, NA Clostridium Difficile Infection (CDI) Surveillance Emerging Infections Program Case Report ,   Clostridium Difficile Infection (CDI) Surveillance Emerging Infections Program Case Report ,   CLOSTRIDIUM DIFFICILE INFECTION (CDI) SURVEILLANCE EMERGING INFECTIONS PROGRAM CASE REPORT CDI Treatment Form NA EIP CDI Surveillance: CDI Case Treatment Questionnaire CDI Telephone Interview CDI Screening Form 2015 ABCs H. Influenzae Neonatal Sepsis Expanded Surveillance Form CDC 10-2015 2015 ABCs H. Influenzae Neonatal Sepsis Expanded Surveillance Form ABCs Case Report Form none, CDC 52.15A REV. 10-2015 ABCsCRF 2015 ,   2016 Active Bacterial Core Surveillance (ABCs) CASE REPORT ABCs Non Bacteremic Pneumococcal Disease CDC, none Non Bacteremic Pneumococcal 2015 ,   2016 Surveillance for Non-Invasive Penumococcal Pneumonia (SNiPP) Invasive Methicillin - Resistant - Staphylococcus aureus ABCs Case Report Form CDC 52.15B Rev 09-2016, none, CDC 52.15B Rev 10-2015 Invasive Methicillin-Resistant Staph ,   Healthcare-Associated Infections Community Interface (HACI) Case Report -2016 ,   Invasive Methicillin-Resistant Staphylococcus aureus HAIC Case Report - 2017 ABCs Invasive Pneumococcal Disease in Children none Invasive Pneumococcal 2015 ABCs Neonatal Infection Expanded Tracking Form none Neonatal Tracking Legionellosis ABCs Case Report none Legionellosis Case Report FluSurv-NET Influenza Hospitalization Surveilance Project Case Report Form CDC Rev 07-2015, none FluSurv-NET Influenza Hospital Surveillance Project ,   2015-16 FluSurv-NET Influenza Hospitalization Surveillance Project Case Report Form Hemolytic Uremic Syndrome (HUS) NA FoodNet Hemolytic Uremic Syndrome (HUS) Surveillance Influenza Hospitalization Surveillance Project Vaccination Telephone Survey none Vaccination Telephone Survey - English FluSurv-Net Project Consent Form none Consent Campylobacter Cryptosporidium Cyclospora Listeria monocytogenes Salmonella

---

ICR Summary of Burden

	Total Approved	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	81,420	81,420	0	0	0	0
Annual Time Burden (Hours)	22,806	22,806	0	0	0	0
Annual Cost Burden (Dollars)	0	0	0	0	0	0

Burden increases because of Program Change due to Agency Discretion: No

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement:

---

Annual Cost to Federal Government: $20,221,865

Does this IC contain surveys, censuses, or employ statistical methods? Yes Part B of Supporting Statement

Is the Supporting Statement intended to be a Privacy Impact Assessment required by the E-Government Act of 2002? No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? Uncollected

Agency Contact: Jeffrey Zirger 404 639-7118 [email protected]

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
		(a) It is necessary for the proper performance of agency functions;
		(b) It avoids unnecessary duplication;
		(c) It reduces burden on small entities;
		(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;
		(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;
		(f) It indicates the retention periods for recordkeeping requirements;
		(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:
			(i) Why the information is being collected;
			(ii) Use of information;
			(iii) Burden estimate;
			(iv) Nature of response (voluntary, required for a benefit, or mandatory);
			(v) Nature and extent of confidentiality; and
			(vi) Need to display currently valid OMB control number;
		(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.
		(i) It uses effective and efficient statistical survey methodology (if applicable); and
		(j) It makes appropriate use of information technology.
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
Certification Date: 12/30/2016

---